Gordon Schanzlin New Vision Institute was one of the original clinical investigators for a U.S. Food and Drug Administration study on the The KAMRA™ corneal inlay. This innovative treatment recently received FDA approval to treat the loss of near vision that is often associated with presbyopia. The KAMRA™ inlay can ...
Continue Reading
Continue Reading